Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE-FLOW: GPIs in MI with No-Reflow
NCT02739711Phase 4Active, not recruiting
- Sponsor
- University of Lübeck
- Start
- Jul 2016
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in myocardial infarction (MI), sponsored by University of Lübeck. Primary endpoint: Infarct size assessed by cardiac magnetic resonance imaging. Started Jul 2016; status: active, not recruiting.
02
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02739711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739711.